PACT Pharma

PACT Pharma is an exciting, well-funded biotechnology company, currently in clinical studies in 2019. #stillhiring

[Nina Kjellson @nkjellson]

PACT Pharma Announces Planned Retirement of CEO Alex Franzusoff; Veteran Biotech Executive Scott Garland Named as ... https://t.co/rjfTSP1F1X

[Vida Ventures @Vida_Ventures]

Vida leads $75M Series C for PACT Pharma for the development of first-in-class personalized cell therapies for solid tumors.

https://t.co/bVgfwfmQyj

[Comprehensive Cell Solutions,New York Blood Center @CcsNybc]

PACT Pharma strives to expand their manufacturing operations of #CellTherapy products, raising $75 million in their Series C financing round. Read about how they plan to develop new cell therapies that target solid tumors ==>https://t.co/Lu4tKtNZBr
#biotech #healthcare

[SY Investing @syinvesting]

Lyell and PACT Pharma announced a strategic partnership to jointly develop and test a next-gen personalized anti-cancer T #CellTherapy against solid tumors.

They will combine technologies to overcome potential tumor resistance and T cell exhaustion.

https://t.co/H4WBox014W

[PACT Pharma @pactpharma]

https://t.co/TZmUBHRd7C